Area of research
Oncology · Immunology
Research interest
Research focused on Fructose and Glucose transporter, with related work in Glycolysis, Flexibility (engineering), Stereotactic radiotherapy. Notable publications include 'Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study', 'The Glucose Transporter 5 Enhances CAR-T Cell Metabolic Function and Anti-tumour Durability', and 'HYBRID CAR T CELLS WITH ENGINEERED FUEL FLEXIBILITY'.
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study
Glucose transporter 5 enhances CAR-T cell metabolic function and serial killing
The Glucose Transporter 5 Enhances CAR-T Cell Metabolic Function and Anti-tumour Durability
HYBRID CAR T CELLS WITH ENGINEERED FUEL FLEXIBILITY